BABA vs BLMN

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite a high dividend yield of 7.83%, the unsustainable payout ratio of 186.49% and negative profitability metrics signal severe earnings pressure. Valuation multiples appear deceptively attractive due to low P/E and P/S ratios, but these are distorted by weak or negative margins and declining earnings. The technical trend is bearish, insider activity shows net selling, and long-term price performance remains deeply negative, reinforcing a high-risk profile.